News

Waste Management, Inc. (WM): I Could Buy It “Consistently,” Says Jim Cramer
We recently published a list of Jim Cramer Finds Elon Musk’s Grok AI Creepy & Discusses These 12 Stocks. In this article, we ...
Macy’s, Inc. (M): “I’m Worried About Macy’s Very Much,” Says Jim Cramer
We recently published a list of Jim Cramer Finds Elon Musk’s Grok AI Creepy & Discusses These 12 Stocks. In this article, we ...
AutoZone (AZO) Is “Not Nearly As Bad As People Think,” Says Jim Cramer
We recently published a list of Jim Cramer Finds Elon Musk’s Grok AI Creepy & Discusses These 12 Stocks. In this article, we ...
Costco Wholesale Corporation (COST): “I Wish It Would Go Up,” Says Jim Cramer
We recently published a list of Jim Cramer Finds Elon Musk’s Grok AI Creepy & Discusses These 12 Stocks. In this article, we ...
United States Steel Corporation (X) Should Not Have Been Bought By Nippon, Says Jim Cramer
We recently published a list of Jim Cramer Finds Elon Musk’s Grok AI Creepy & Discusses These 12 Stocks. In this article, we ...
General Motors Company (GM) Has Jim Cramer “Concerned”
We recently published a list of Jim Cramer Finds Elon Musk’s Grok AI Creepy & Discusses These 12 Stocks. In this article, we ...
The Walt Disney Company (DIS): “The Stock Can Go Much Higher,” Says Jim Cramer
We recently published a list of Jim Cramer Finds Elon Musk’s Grok AI Creepy & Discusses These 12 Stocks. In this article, we ...
Ford Motor Company (F): “I’m Just Very Concerned” About It, Says Jim Cramer
We recently published a list of Jim Cramer Finds Elon Musk’s Grok AI Creepy & Discusses These 12 Stocks. In this article, we ...
Okta, Inc. (OKTA) Is A “Remarkable Company,” Says Jim Cramer
We recently published a list of Jim Cramer Finds Elon Musk’s Grok AI Creepy & Discusses These 12 Stocks. In this article, we ...
Bank of America Hires JPMorgan Executive to Lead India Equity Markets Unit
Recently, the company has tapped Satish Arcot from JPMorgan Chase to lead its capital markets division in India, as part of ...
AbbVie Secures FDA Approval to Expand Mavyret’s Label
The company announced that the US FDA has expanded the approved use of its oral antiviral drug Mavyret, developed in ...